Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04922294 · ClinicalTrials.gov registry record

Implementation of a Cardiometabolic Disease Staging System in Primary Care

A clinical trial of Obesity and Diabetes, sponsored by University of Alabama at Birmingham.

Completed
Registry status
10
Enrollment target
1
Study location

NCT04922294 is a study of Obesity and Diabetes that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 10 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04922294, a study of Obesity and Diabetes, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to develop a clinical decision support system (CDSS) that incorporates obesity management guidelines and treatment options for use by physicians and, potentially, patients based on a cardiometabolic disease staging system. This CDSS will be designed using primary care provider input through a qualitative approach to explore physician preferences for the appearance, electronic location, treatment options, referrals, accessibility and other user requirements of the CDSS.

Interventions

  • OTHER Clinical decision support system

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2020-07-20
Est. Completion 2022-12-05

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04922294

The ClinicalTrials.gov registry entry for NCT04922294 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (99% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Clinical decision support system is the first listed.

NCT04922294 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT04922294 about?

NCT04922294 is a clinical study titled "Implementation of a Cardiometabolic Disease Staging System in Primary Care". The aim of this study is to develop a clinical decision support system (CDSS) that incorporates obesity management guidelines and treatment options for use by physicians and, potentially, patients based on a cardiometabolic disease staging system. This CDSS will be designed using primary care provid...

What is the current status of trial NCT04922294?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2020-07-20. Estimated completion is 2022-12-05.

What conditions does trial NCT04922294 study?

This clinical trial studies the following conditions: Obesity, Diabetes, Overweight.

What interventions are being tested in trial NCT04922294?

The interventions under investigation include: Clinical decision support system (OTHER).

Who is sponsoring clinical trial NCT04922294?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04922294 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.